Objectives: The aim of this paper is to present an overview on the current state of knowledge of the epidemiology, aetiology/risk factors, pain mechanisms, diagnosis and management of dentin hypersensitivity. Available products for treatment of dentin hypersensitivity are presented and the scientific and clinical research validating their efficacy is reviewed. Material and methods: Original papers, reviews and guidelines on this subject, published in English form 2009 to 2013, were retrieved from Medline/Pubmed database. Additional publications were obtained by searching the reference list of retrieved works. Results and conclusions: The management of dentin hypersensitivity is based on the control of causal factors and the application, at-home or in-office, of various products which are aimed to occlude patent tubules. In vitro methods suffer from some limitations to mimicking the “real-life” individual behaviours and the ecological variables of the oral environment, then randomized and controlled clinical trials are considered the gold standard to evaluate the efficacy of these products. The arginine-calcium carbonate complex has demonstrated to be efficacious in providing instant and long-lasting relief. Further randomized and controlled clinical studies are needed to confirm the results of amorphous sodium calcium phosphosilicate and strontium acetate.

Obiettivi. Scopo di questo lavoro è presentare le più recenti acquisizioni in tema di epidemiologia, diagnosi, eziopatogenesi e management clinico dell’ipersensibilità dentinale. Vengono inoltre descritti i prodotti disponibili per il suo trattamento e gli studi sperimentali e clinici condotti per valutarne l’efficacia. Materiali e metodi. Attraverso la banca dati Medline/Pubmed sono stati selezionati i lavori originali, le revisioni della letteratura e le linee guida pubblicate in lingua inglese e in italiano sull’argomento dal 2009 al 2013. Altre fonti sono state selezionate dai riferimenti bibliografici individuati. Risultati e conclusioni. Il management dell’ipersensibilità prevede il controllo dei fattori causali e l’applicazione domiciliare/professionale di prodotti contenenti agenti occludenti. Gli studi in vitro non possono riprodurre del tutto i comportamenti quotidiani dei pazienti e le variabili ecologiche del cavo orale. L’efficacia di tali prodotti pertanto deve essere valutata mediante studi clinici randomizzati e controllati. Il complesso arginina-carbonato di calcio ha dato prova di efficacia nell’indurre sollievo immediato e duraturo. Sono necessari ulteriori trial clinici, randomizzati e controllati, per confermare i risultati relativi al fosfosilicato di calcio-sodio e all’acetato di stronzio.

Cruciata, F., Pizzo, G. (2014). Il management dell’ipersensibilità dentinale: dalla ricerca alla clinica. DENTAL CADMOS, 82(8), 552-572.

Il management dell’ipersensibilità dentinale: dalla ricerca alla clinica

PIZZO, Giuseppe
2014-01-01

Abstract

Objectives: The aim of this paper is to present an overview on the current state of knowledge of the epidemiology, aetiology/risk factors, pain mechanisms, diagnosis and management of dentin hypersensitivity. Available products for treatment of dentin hypersensitivity are presented and the scientific and clinical research validating their efficacy is reviewed. Material and methods: Original papers, reviews and guidelines on this subject, published in English form 2009 to 2013, were retrieved from Medline/Pubmed database. Additional publications were obtained by searching the reference list of retrieved works. Results and conclusions: The management of dentin hypersensitivity is based on the control of causal factors and the application, at-home or in-office, of various products which are aimed to occlude patent tubules. In vitro methods suffer from some limitations to mimicking the “real-life” individual behaviours and the ecological variables of the oral environment, then randomized and controlled clinical trials are considered the gold standard to evaluate the efficacy of these products. The arginine-calcium carbonate complex has demonstrated to be efficacious in providing instant and long-lasting relief. Further randomized and controlled clinical studies are needed to confirm the results of amorphous sodium calcium phosphosilicate and strontium acetate.
2014
Settore MED/28 - Malattie Odontostomatologiche
Cruciata, F., Pizzo, G. (2014). Il management dell’ipersensibilità dentinale: dalla ricerca alla clinica. DENTAL CADMOS, 82(8), 552-572.
File in questo prodotto:
File Dimensione Formato  
Dental Cadmos 2014.pdf

Solo gestori archvio

Descrizione: articolo principale
Dimensione 1.37 MB
Formato Adobe PDF
1.37 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Dental Cadmos 2014-def.pdf

Solo gestori archvio

Dimensione 2.36 MB
Formato Adobe PDF
2.36 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/101960
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact